Global Canine Influenza Vaccine Market Growth 2022-2028
- LP 4794681
- 75 Pages
- January 2022
- Pharmaceuticals
The United States Canine Influenza Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Canine Influenza Vaccine market, reaching US$ million by the year 2028. As for the Europe Canine Influenza Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Canine Influenza Vaccine players cover Merck Animal Health, Zoetis, CSL Limited, and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Canine Influenza Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Liquid
Powder
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Home
Pet Clinic
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Merck Animal Health
Zoetis
CSL Limited
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Canine Influenza Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Canine Influenza Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Canine Influenza Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Canine Influenza Vaccine Segment by Type
2.2.1 Liquid
2.2.2 Powder
2.3 Canine Influenza Vaccine Sales by Type
2.3.1 Global Canine Influenza Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Canine Influenza Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Canine Influenza Vaccine Sale Price by Type (2017-2022)
2.4 Canine Influenza Vaccine Segment by Application
2.4.1 Home
2.4.2 Pet Clinic
2.4.3 Others
2.5 Canine Influenza Vaccine Sales by Application
2.5.1 Global Canine Influenza Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Canine Influenza Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Canine Influenza Vaccine Sale Price by Application (2017-2022)
3 Global Canine Influenza Vaccine by Company
3.1 Global Canine Influenza Vaccine Breakdown Data by Company
3.1.1 Global Canine Influenza Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Canine Influenza Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Canine Influenza Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Canine Influenza Vaccine Revenue by Company (2020-2022)
3.2.2 Global Canine Influenza Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Canine Influenza Vaccine Sale Price by Company
3.4 Key Manufacturers Canine Influenza Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Canine Influenza Vaccine Product Location Distribution
3.4.2 Players Canine Influenza Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Canine Influenza Vaccine by Geographic Region
4.1 World Historic Canine Influenza Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Canine Influenza Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Canine Influenza Vaccine Annual Revenue by Geographic Region
4.2 World Historic Canine Influenza Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Canine Influenza Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Canine Influenza Vaccine Annual Revenue by Country/Region
4.3 Americas Canine Influenza Vaccine Sales Growth
4.4 APAC Canine Influenza Vaccine Sales Growth
4.5 Europe Canine Influenza Vaccine Sales Growth
4.6 Middle East & Africa Canine Influenza Vaccine Sales Growth
5 Americas
5.1 Americas Canine Influenza Vaccine Sales by Country
5.1.1 Americas Canine Influenza Vaccine Sales by Country (2017-2022)
5.1.2 Americas Canine Influenza Vaccine Revenue by Country (2017-2022)
5.2 Americas Canine Influenza Vaccine Sales by Type
5.3 Americas Canine Influenza Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Canine Influenza Vaccine Sales by Region
6.1.1 APAC Canine Influenza Vaccine Sales by Region (2017-2022)
6.1.2 APAC Canine Influenza Vaccine Revenue by Region (2017-2022)
6.2 APAC Canine Influenza Vaccine Sales by Type
6.3 APAC Canine Influenza Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Canine Influenza Vaccine by Country
7.1.1 Europe Canine Influenza Vaccine Sales by Country (2017-2022)
7.1.2 Europe Canine Influenza Vaccine Revenue by Country (2017-2022)
7.2 Europe Canine Influenza Vaccine Sales by Type
7.3 Europe Canine Influenza Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Canine Influenza Vaccine by Country
8.1.1 Middle East & Africa Canine Influenza Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Canine Influenza Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Canine Influenza Vaccine Sales by Type
8.3 Middle East & Africa Canine Influenza Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Canine Influenza Vaccine
10.3 Manufacturing Process Analysis of Canine Influenza Vaccine
10.4 Industry Chain Structure of Canine Influenza Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Canine Influenza Vaccine Distributors
11.3 Canine Influenza Vaccine Customer
12 World Forecast Review for Canine Influenza Vaccine by Geographic Region
12.1 Global Canine Influenza Vaccine Market Size Forecast by Region
12.1.1 Global Canine Influenza Vaccine Forecast by Region (2023-2028)
12.1.2 Global Canine Influenza Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Canine Influenza Vaccine Forecast by Type
12.7 Global Canine Influenza Vaccine Forecast by Application
13 Key Players Analysis
13.1 Merck Animal Health
13.1.1 Merck Animal Health Company Information
13.1.2 Merck Animal Health Canine Influenza Vaccine Product Offered
13.1.3 Merck Animal Health Canine Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Merck Animal Health Main Business Overview
13.1.5 Merck Animal Health Latest Developments
13.2 Zoetis
13.2.1 Zoetis Company Information
13.2.2 Zoetis Canine Influenza Vaccine Product Offered
13.2.3 Zoetis Canine Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Zoetis Main Business Overview
13.2.5 Zoetis Latest Developments
13.3 CSL Limited
13.3.1 CSL Limited Company Information
13.3.2 CSL Limited Canine Influenza Vaccine Product Offered
13.3.3 CSL Limited Canine Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 CSL Limited Main Business Overview
13.3.5 CSL Limited Latest Developments
14 Research Findings and Conclusion
Table 1. Canine Influenza Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Canine Influenza Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Liquid
Table 4. Major Players of Powder
Table 5. Global Canine Influenza Vaccine Sales by Type (2017-2022) & (K Doses)
Table 6. Global Canine Influenza Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global Canine Influenza Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Canine Influenza Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global Canine Influenza Vaccine Sale Price by Type (2017-2022) & (USD/Dose)
Table 10. Global Canine Influenza Vaccine Sales by Application (2017-2022) & (K Doses)
Table 11. Global Canine Influenza Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global Canine Influenza Vaccine Revenue by Application (2017-2022)
Table 13. Global Canine Influenza Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global Canine Influenza Vaccine Sale Price by Application (2017-2022) & (USD/Dose)
Table 15. Global Canine Influenza Vaccine Sales by Company (2020-2022) & (K Doses)
Table 16. Global Canine Influenza Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global Canine Influenza Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Canine Influenza Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global Canine Influenza Vaccine Sale Price by Company (2020-2022) & (USD/Dose)
Table 20. Key Manufacturers Canine Influenza Vaccine Producing Area Distribution and Sales Area
Table 21. Players Canine Influenza Vaccine Products Offered
Table 22. Canine Influenza Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Canine Influenza Vaccine Sales by Geographic Region (2017-2022) & (K Doses)
Table 26. Global Canine Influenza Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Canine Influenza Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Canine Influenza Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Canine Influenza Vaccine Sales by Country/Region (2017-2022) & (K Doses)
Table 30. Global Canine Influenza Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Canine Influenza Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Canine Influenza Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Canine Influenza Vaccine Sales by Country (2017-2022) & (K Doses)
Table 34. Americas Canine Influenza Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas Canine Influenza Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Canine Influenza Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas Canine Influenza Vaccine Sales by Type (2017-2022) & (K Doses)
Table 38. Americas Canine Influenza Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas Canine Influenza Vaccine Sales by Application (2017-2022) & (K Doses)
Table 40. Americas Canine Influenza Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC Canine Influenza Vaccine Sales by Region (2017-2022) & (K Doses)
Table 42. APAC Canine Influenza Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC Canine Influenza Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Canine Influenza Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC Canine Influenza Vaccine Sales by Type (2017-2022) & (K Doses)
Table 46. APAC Canine Influenza Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC Canine Influenza Vaccine Sales by Application (2017-2022) & (K Doses)
Table 48. APAC Canine Influenza Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe Canine Influenza Vaccine Sales by Country (2017-2022) & (K Doses)
Table 50. Europe Canine Influenza Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe Canine Influenza Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Canine Influenza Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe Canine Influenza Vaccine Sales by Type (2017-2022) & (K Doses)
Table 54. Europe Canine Influenza Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe Canine Influenza Vaccine Sales by Application (2017-2022) & (K Doses)
Table 56. Europe Canine Influenza Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Canine Influenza Vaccine Sales by Country (2017-2022) & (K Doses)
Table 58. Middle East & Africa Canine Influenza Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Canine Influenza Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Canine Influenza Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Canine Influenza Vaccine Sales by Type (2017-2022) & (K Doses)
Table 62. Middle East & Africa Canine Influenza Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Canine Influenza Vaccine Sales by Application (2017-2022) & (K Doses)
Table 64. Middle East & Africa Canine Influenza Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Canine Influenza Vaccine
Table 66. Key Market Challenges & Risks of Canine Influenza Vaccine
Table 67. Key Industry Trends of Canine Influenza Vaccine
Table 68. Canine Influenza Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Canine Influenza Vaccine Distributors List
Table 71. Canine Influenza Vaccine Customer List
Table 72. Global Canine Influenza Vaccine Sales Forecast by Region (2023-2028) & (K Doses)
Table 73. Global Canine Influenza Vaccine Sales Market Forecast by Region
Table 74. Global Canine Influenza Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Canine Influenza Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Canine Influenza Vaccine Sales Forecast by Country (2023-2028) & (K Doses)
Table 77. Americas Canine Influenza Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Canine Influenza Vaccine Sales Forecast by Region (2023-2028) & (K Doses)
Table 79. APAC Canine Influenza Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Canine Influenza Vaccine Sales Forecast by Country (2023-2028) & (K Doses)
Table 81. Europe Canine Influenza Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Canine Influenza Vaccine Sales Forecast by Country (2023-2028) & (K Doses)
Table 83. Middle East & Africa Canine Influenza Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Canine Influenza Vaccine Sales Forecast by Type (2023-2028) & (K Doses)
Table 85. Global Canine Influenza Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Canine Influenza Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Canine Influenza Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Canine Influenza Vaccine Sales Forecast by Application (2023-2028) & (K Doses)
Table 89. Global Canine Influenza Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Canine Influenza Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Canine Influenza Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. Merck Animal Health Basic Information, Canine Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Merck Animal Health Canine Influenza Vaccine Product Offered
Table 94. Merck Animal Health Canine Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 95. Merck Animal Health Main Business
Table 96. Merck Animal Health Latest Developments
Table 97. Zoetis Basic Information, Canine Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Zoetis Canine Influenza Vaccine Product Offered
Table 99. Zoetis Canine Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 100. Zoetis Main Business
Table 101. Zoetis Latest Developments
Table 102. CSL Limited Basic Information, Canine Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. CSL Limited Canine Influenza Vaccine Product Offered
Table 104. CSL Limited Canine Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 105. CSL Limited Main Business
Table 106. CSL Limited Latest Developments
List of Figures
Figure 1. Picture of Canine Influenza Vaccine
Figure 2. Canine Influenza Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Canine Influenza Vaccine Sales Growth Rate 2017-2028 (K Doses)
Figure 7. Global Canine Influenza Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Canine Influenza Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Liquid
Figure 10. Product Picture of Powder
Figure 11. Global Canine Influenza Vaccine Sales Market Share by Type in 2021
Figure 12. Global Canine Influenza Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. Canine Influenza Vaccine Consumed in Home
Figure 14. Global Canine Influenza Vaccine Market: Home (2017-2022) & (K Doses)
Figure 15. Canine Influenza Vaccine Consumed in Pet Clinic
Figure 16. Global Canine Influenza Vaccine Market: Pet Clinic (2017-2022) & (K Doses)
Figure 17. Canine Influenza Vaccine Consumed in Others
Figure 18. Global Canine Influenza Vaccine Market: Others (2017-2022) & (K Doses)
Figure 19. Global Canine Influenza Vaccine Sales Market Share by Application (2017-2022)
Figure 20. Global Canine Influenza Vaccine Revenue Market Share by Application in 2021
Figure 21. Canine Influenza Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Canine Influenza Vaccine Revenue Market Share by Company in 2021
Figure 23. Global Canine Influenza Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Canine Influenza Vaccine Revenue Market Share by Geographic Region in 2021
Figure 25. Global Canine Influenza Vaccine Sales Market Share by Region (2017-2022)
Figure 26. Global Canine Influenza Vaccine Revenue Market Share by Country/Region in 2021
Figure 27. Americas Canine Influenza Vaccine Sales 2017-2022 (K Doses)
Figure 28. Americas Canine Influenza Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. APAC Canine Influenza Vaccine Sales 2017-2022 (K Doses)
Figure 30. APAC Canine Influenza Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Europe Canine Influenza Vaccine Sales 2017-2022 (K Doses)
Figure 32. Europe Canine Influenza Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Canine Influenza Vaccine Sales 2017-2022 (K Doses)
Figure 34. Middle East & Africa Canine Influenza Vaccine Revenue 2017-2022 ($ Millions)
Figure 35. Americas Canine Influenza Vaccine Sales Market Share by Country in 2021
Figure 36. Americas Canine Influenza Vaccine Revenue Market Share by Country in 2021
Figure 37. United States Canine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Canine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Canine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Canine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Canine Influenza Vaccine Sales Market Share by Region in 2021
Figure 42. APAC Canine Influenza Vaccine Revenue Market Share by Regions in 2021
Figure 43. China Canine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Canine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Canine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Canine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Canine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Canine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Canine Influenza Vaccine Sales Market Share by Country in 2021
Figure 50. Europe Canine Influenza Vaccine Revenue Market Share by Country in 2021
Figure 51. Germany Canine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Canine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Canine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Canine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Canine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Canine Influenza Vaccine Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Canine Influenza Vaccine Revenue Market Share by Country in 2021
Figure 58. Egypt Canine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Canine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Canine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Canine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Canine Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Canine Influenza Vaccine in 2021
Figure 64. Manufacturing Process Analysis of Canine Influenza Vaccine
Figure 65. Industry Chain Structure of Canine Influenza Vaccine
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
